FORWARD FEATURES CALENDAR

Find us on

Latest News

Keensight Capital, a private equity manager dedicated to pan-European Growth Buyout investments, is to sell its stake in Linkbynet, a provider of cloud, Devops and cyber security services.  This sale would take place in the context of the proposed acquisition of the company by Accenture. Founded in 2000, Linkbynet is a cloud-native solutions provider with offices in France, Belgium, Canada, China, Luxembourg, Mauritius, Singapore and Vietnam. The company’s team is comprised of more than 900 highly skilled professionals with 400 certifications from major cloud providers such as Amazon, Google, Microsoft or Alibaba. Keensight Capital, as a shareholder of Linkbynet since
The Board of Directors of the African Private Equity and Venture Capital Association (AVCA) have appointed Kofo Sanusi as Chief Operating Officer (COO).   Sanusi joins AVCA from Founders Factory Africa (FFA), a venture development company investing in start-ups in sub-Saharan Africa. As Chief Operating Officer and Accelerator Director, she was responsible for overseeing the company’s financial and operational activities and leading investments and support to early-stage start-ups to scale across Africa. Abi Mustapha-Maduakor, AVCA CEO, says: “Kofo is the right person to support the Association as we implement the strategic vision and continue to deliver value for our members.
Cambridge based biotechnology company, Phico Therapeutics (Phico), has received GBP7 million in funding from a consortium of investors. BGF, the UK and Ireland’s most active growth capital investor, led the round with a GBP3 million investment, while a further GBP4 million was received from existing backers. Founded in 2000 by Dr Heather Fairhead, Phico is developing a biotechnology platform for a new generation of antibiotics to overcome antibacterial resistance. Antibiotic resistance is recognised internationally as one of the biggest threats facing global health and the effective treatment of certain diseases. It is estimated that drug resistant infections cause over 700,000
Kirkland & Ellis has appointed Gregory Scott as a partner in the Corporate Practice Group in the firm’s London office.  Scott advises private equity houses and other financial sponsor clients on all types of M&A transactions including leveraged buy-outs, carve-outs, mergers and exits across a variety of business sectors.   Scott will join Kirkland from the London office of Clifford Chance.   Kirkland’s dedicated private equity practice is the largest in the European market, acting for a diverse mix of top private equity and financial sponsor clients on multiple deals across multiple sectors and geographies. Kirkland advises across the full
Pulsar Health is joining imc group with the full support of pan-European investor Waterland Private Equity.  Located in Cheadle, North West England, Pulsar Health’s ethos and expertise prioritise a ‘one team’ approach to meet clients’ scientific and marketing objectives, making the company a natural partner for imc group.  The partnership will enable imc to continue disrupting the global healthcare communications industry with a one-stop service for clients across seven core divisions: Medical & Scientific Content, Publications, Digital & Creative, Insights & Consulting, Patient Engagement, Meetings & Events, and Medical Compliance & Material Review. With over 20 years of experience, Pulsar
MIG Verwaltungs AG (MIG AG), one of the leading German venture capital firms, has participated in the EUR29 million series C financing of AMSilk GmbH, Munich. MIG has backed AMSilk since 2008 with capital from several of its funds.  In addition to the continued support from seed investors MIG and Athos KG, new to AMSilk are Danish Novo Holdings, the US Cargill group and ER Capital which also joined the current financing round. “With the strong team around CEO Ulrich Scherbel and support of the extended circle of investors, AMSilk is in a good position to scale up its proven
Delivery Hero-backed DX Ventures has invested in Bluu Biosciences as part of the company’s seed funding round.  Bluu Biosciences is the first company in Europe to specialise in the development and production of cell-based fish using advanced biotechnology. Cell-based or cultivated fish is sustainable fish meat produced from real fish cells that is grown in a bioreactor. It is an animal product that, unlike wild-caught fish, is obtained without compromising animal welfare.  According to the Food and Agriculture Organisation of the United Nations, about 90 per cent of all edible fish stocks are already considered maximally exploited or overfished, while
finncap Cavendish (Cavendish), part of financial advisory firm, finnCap Group, has has advised on the sale of a majority stake in Xexec Ltd (Xexec), an employee engagement tech firm, to funds advised by Castik Capital (Castik) and Boston-based private equity firm, Abry Partners (Abry). Headquartered in London, Xexec is an employee engagement provider that offers a wide range of employee discounts and reward & recognition solutions through its scalable cloud-based platform. The company also offers customer loyalty programs which enables corporate clients to engage with and retain their own end-customers.   Xexec has proven to be a fast growing and
Global Energy Storage (GES) has launched, with the intention of investing USD250 million, with the backing of private equity firm Bluewater, in energy transition. GES has been set up by the management team from Global Petro Storage (GPS), the leading independent hydrocarbon storage and logistics company. The team will build on the successful model they developed at that company. The management team will continue to work across both GPS and GES. GES will focus on key global hubs and growth locations, international cross-linking business, and long-term relationships with top-tier energy suppliers. Its focus will be on low carbon and energy
Family Legacy Capital Management (FLC), a private investment manager for family offices, has launched FLC Credit Partners, a private credit fund manager. Read the full story at Wealth Adviser…

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings